We are live on ! Find out more
ACM

Ashford Capital Management Portfolio holdings

AUM $809M
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.15%
5 Year Est. Return
+109.93%
10 Year Est. Return
+1,281.08%
AUM
$841M
AUM Growth
+$69.2M
Cap. Flow
-$4.93M
Cap. Flow %
-0.59%
Top 10 Hldgs %
37.42%
Holding
104
New
7
Increased
29
Reduced
51
Closed
7

Top Sells

Rank Stock Value
1
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$32.9M
2
TTD icon
Trade Desk
TTD
+$8.76M
3
FIVE icon
Five Below
FIVE
+$7.28M
4
TWLO icon
Twilio
TWLO
+$6.07M
5
SHOP icon
Shopify
SHOP
+$5.43M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 16.31%
3 Communication Services 15.04%
4 Healthcare 11.48%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRO icon
76
Brown & Brown
BRO
$23.9B
$634K 0.08%
14,000
MORN icon
77
Morningstar
MORN
$7.53B
$613K 0.07%
3,819
+526
+16% +$83.1K
WWD icon
78
Woodward
WWD
$21.4B
$601K 0.07%
7,501
+853
+13% +$68.6K
TECH icon
79
Bio-Techne
TECH
$11.3B
$528K 0.06%
8,524
+5,224
+158% +$340K
LGND icon
80
Ligand Pharmaceuticals
LGND
$6.36B
$499K 0.06%
8,400
-641
-7% -$43.7K
MELI icon
81
Mercado Libre
MELI
$92.3B
$433K 0.05%
400
-50
-11% -$54.3K
SPY icon
82
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$422K 0.05%
+1,259
New +$417K
BX icon
83
Blackstone
BX
$110B
$407K 0.05%
7,800
-1,000
-11% -$53.5K
MRK icon
84
Merck
MRK
$318B
$373K 0.04%
4,716
-210
-4% -$16.4K
JNJ icon
85
Johnson & Johnson
JNJ
$625B
$328K 0.04%
2,200
MXIM
86
DELISTED
Maxim Integrated Products
MXIM
$270K 0.03%
4,000
GLW icon
87
Corning
GLW
$143B
$264K 0.03%
8,136
DDOG icon
88
Datadog
DDOG
$84B
$255K 0.03%
2,500
-4,454
-64% -$388K
T icon
89
AT&T
T
$163B
$253K 0.03%
11,770
TROW icon
90
T. Rowe Price
TROW
$24.3B
$251K 0.03%
1,959
BMY icon
91
Bristol-Myers Squibb
BMY
$132B
$238K 0.03%
3,950
-1,000
-20% -$60.2K
VZ icon
92
Verizon
VZ
$196B
$233K 0.03%
3,913
-2,000
-34% -$116K
BIIB icon
93
Biogen
BIIB
$30.7B
$227K 0.03%
800
-200
-20% -$55.8K
UDR icon
94
UDR
UDR
$12.3B
$226K 0.03%
6,916
-1,750
-20% -$61.4K
ILMN icon
95
Illumina
ILMN
$28.4B
$223K 0.03%
740
-72
-9% -$24.8K
PG icon
96
Procter & Gamble
PG
$339B
$203K 0.02%
+1,462
New +$194K
RA
97
Brookfield Real Assets Income Fund
RA
$708M
$175K 0.02%
10,622
-176,892
-94% -$3M
CVX icon
98
Chevron
CVX
$366B
-2,670
Closed -$238K
INTC icon
99
Intel
INTC
$513B
-4,400
Closed -$263K
LLY icon
100
Eli Lilly
LLY
$1.06T
-1,366
Closed -$224K

Similar funds

Ashford Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Ashford Capital Management held 104 positions worth $841M, up 9% from $772M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ashford Capital Management's Q3 2020 filing shows 7 new, 29 increased, 51 reduced and 7 closed positions. Its largest new stake was Health Catalyst: 342,500 shares worth $12.5M. The largest sale was Livongo Health, Inc. Common Stock, an estimated $32.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Industrials and Communication Services.

  • Ashford Capital Management's largest Q3 2020 buy was Health Catalyst: 342,500 shares worth $12.5M.
  • Ashford Capital Management added most to Smartsheet Inc. in Q3 2020, an estimated $11.3M increase.
  • Ashford Capital Management's biggest Q3 2020 reduction was Livongo Health, Inc. Common Stock, cutting an estimated $32.9M.
  • Ashford Capital Management fully exited Ebix Inc in Q3 2020, selling an estimated $4.43M.
  • Ashford Capital Management's ten largest holdings make up 37% of its $841M portfolio in Q3 2020.
  • Ashford Capital Management opened 7 new positions and closed 7 in Q3 2020.
  • Ashford Capital Management's portfolio value rose 9% quarter-over-quarter to $841M.

Based on Ashford Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.